Crossmark

Characterization of primary normal and malignant breast cancer cell and their response to chemotherapy and immunostimulatory agents

Crossref DOI link: https://doi.org/10.1186/s12885-018-4635-8

Published Online: 2018-07-09

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Nushtaeva, Anna A.

Stepanov, Grigory A.

Semenov, Dmitry V.

Juravlev, Evgeny S.

Balahonova, Evgenia A.

Gerasimov, Alexey V.

Sidorov, Sergey V.

Savelyev, Eugeniy I.

Kuligina, Elena V.

Richter, Vladimir A.

Koval, Olga A. http://orcid.org/0000-0001-7788-2249
Funding

Funding for this research was provided by:

Russian Science Foundation (16-14-10284)

Russian Foundation for Basic Research (16-34-60136)
License Information

Text and Data Mining valid from 2018-07-09
More Information

Article History

Received: 10 November 2017

Accepted: 25 June 2018

First Online: 9 July 2018

Ethics approval and consent to participate

: All patients gave written informed consent. The study protocol was approved by the Institute of Molecular Biology and Biophysics SB RAMS Ethics Committee in accordance with the Declaration of Helsinki of 1975.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.